42 They can migrate to specific injury sites and differentiate into multiple cells and tissues, such as glial cells, neurons, or chondrogenic tissues
This metabolic shift occurs without stimulating appetite suppression or increasing nervous system activity, making it fundamentally different from traditional weight loss compounds
Stress, hormones, and inflammation create a hostile environment
Oral administration, when using acetate or amidate-stabilized KLOW formulations, delays onset by 4070 minutes due to gastric transit time and first-pass hepatic metabolism, which reduces bioavailability to approximately 3045%
Mitophagy, a potential therapeutic target for stroke
Dilip Shanghvi, Managing Director, Sun Pharma said, We are excited by the robust pre-clinical data for GL0034 and believe that it has significant potential